Clinical Trial Update: Trichuris Suis Ova Therapy for Relapsing Multiple Sclerosis - a Safety Study [Phase 2]

View source ↗

Summary

A Phase 2 safety study of Trichuris suis ova therapy for relapsing multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• Trichuris suis ova therapy (Trichuris suis ova)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Relapsing Multiple Sclerosis | Phase 2 | Status: COMPLETED